One of the key drivers of growth in the orthobiologics market is the continuous advancements in technology and product innovation. Manufacturers are investing in research and development to introduce new and improved orthobiologic products. For instance, the development of three-dimensional (3D) printing technology has revolutionized the production of patient-specific implants and scaffolds, offering enhanced precision and customization. Additionally, advancements in biomaterials, such as synthetic bone graft substitutes, have improved their biocompatibility and osteoinductive properties.
The global Orthobiologics Marketis estimated to be valued at US$ 6,515.2 million in 2022 and is expected to exhibit a CAGR of 5.9% during the forecast period (2022-2030). The prevalence of orthopedic conditions, such as osteoarthritis, fractures, and musculoskeletal disorders, is increasing globally, primarily due to aging populations and sedentary lifestyles. These conditions often require surgical intervention, creating a significant demand for orthobiologic products. The growing awareness of these treatments among patients and healthcare professionals has further propelled market growth. Moreover, the adoption of minimally invasive surgical techniques has increased the utilization of orthobiologics as they facilitate faster recovery and reduced post-operative complications.
Explore More- https://cmi-latestreportorientedblogs.blogspot.com/2023/06/orthobiologics-market-ready-to-achieve.html
Comments
0 comment